Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Mechanistic effects of IVIg in neuroinflammatory diseases: conclusions based on clinicopathologic correlations.
[inclusion body myositis]
The
mechanisms
of
action
of
IVIg
on
immunoregulatory
and
neuroinflammatory
network
have
been
predominantly
based
on
in
vitro
experiments
and
animal
studies
,
rather
than
direct
effects
on
human
tissues
.
Based
on
clinicopathologic
correlations
and
tissues
obtained
before
and
after
IVIg
therapy
,
the
better
documented
and
clinically-relevant
in
-vivo
actions
of
IVIg
include
effects
on
:
a
)
Antibodies
.
An
extracted
antigen-
specific
anti-immunoglobulin
(
idiotypic
)
fraction
appears
partially
responsible
for
its
effect
in
myasthenia
gravis
and
GBS
;
b
)
Complement
.
Sera
from
Dermatomyositis
(
DM
)
patients
responding
to
IVIg
,
inhibit
complement
consumption
and
intercept
MAC
formation
leading
to
disappearance
of
MAC
deposits
in
the
repeated
muscle
biopsies
and
normalization
of
muscle
tissue
;
c
)
Genes
.
In
repeated
muscle
biopsies
from
DM
patients
who
improved
after
IVIg
,
but
not
from
Inclusion-
Body-
Myositis
(
IBM
)
who
did
not
improve
,
there
is
a
2
-
fold
alteration
of
2206
tissue
genes
associated
with
inflammation
,
fibrosis
,
tissue
remodeling
and
regeneration
;
and
d
)
degenerative-proinflammatory
molecules
and
β-amyloid
,
implicated
in
neurodegenerative
CNS
diseases
and
IBM
.
In
repeated
muscle
biopsies
of
IBM
patients
who
did
not
respond
to
IVIg
,
the
mRNA
or
protein
expression
for
chemokines
,
IFN-γ
,
TGF-ß
,
IL
-
10
,
Ubiquitin
and
aB-crystallin
is
reduced
,
but
not
for
the
key
molecules
ICOS
,
ICOSL
,
IL
-
6
,
IL
1
-
β
,
perforin
,
APP
,
nitric
oxide
synthase
and
nitrotyrosine
,
in
spite
of
good
IVIg
penetration
in
muscles
.
Collectively
,
the
selective
effectiveness
of
IVIg
in
human
diseases
seems
to
correlate
in
vivo
with
inhibition
of
causative
inflammatory
mediators
.
Study
of
accessible
tissues
before
and
after
therapy
and
clinicopathologic
correlations
,
may
help
explain
the
differential
effect
of
IVIg
in
autoimmune
or
neuroinflammatory
diseases
.
Diseases
Validation
Diseases presenting
"repeated muscle biopsies and normalization of muscle tissue"
symptom
inclusion body myositis
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom